Restriction of LABA use to combination ICS/LABA inhaler therapy in asthma

被引：7
|
作者：
Beasley, Richard [1 ,2 ]
Fingleton, James [1 ,2 ]
Weatherall, Mark [2 ,3 ]
机构：
[1] Med Res Inst New Zealand, Dept Internal Med, Wellington 6242, New Zealand
[2] Capital & Coast Dist Hlth Board, Dept Internal Med, Wellington, New Zealand
[3] Univ Otago Wellington, Dept Med, Wellington, New Zealand
来源：
THORAX | 2013年 / 68卷 / 02期
关键词：
RANDOMIZED CONTROLLED-TRIALS; FLUTICASONE PROPIONATE; EXTERNAL VALIDITY; SALMETEROL; CORTICOSTEROIDS; ADHERENCE; ADULTS; RISK; METAANALYSIS; MORTALITY;
D O I：
10.1136/thoraxjnl-2012-202483
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [21] Use of ICS/LABA on Asthma Exacerbation Risk in Patients Within a Medical Group
    Stanford, Richard H.
    Nagar, Saurabh
    Lin, Xiwu
    O'Connor, Richard D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (11): : 1014 - 1019
  • [22] The MiSTIC Study Design: Medium Strength Triple Therapy Vs High Strength ICS/LABA for Adult Patients With Asthma Uncontrolled on Medium Strength ICS/LABA
    Kostikas, K.
    Topole, E.
    Singh, D.
    Brusselle, G. G.
    Kots, M.
    Vele, A.
    Georges, G.
    Papi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [23] COMPARISON OF LAMA/LABA AND ICS/LABA AS INITIAL TREATMENT FOR COPD
    Aoyama, Junichi
    Tanaka, Yosuke
    Kosaihira, Seiji
    Okano, Tetuya
    Hino, Mitunori
    Seike, Masahiro
    Gemma, Akihiko
    RESPIROLOGY, 2019, 24 : 165 - 165
  • [24] COPD Exacerbations And Pneumonia On Triple Therapy (fixed Ics/laba Combinations And Tiotropium). Does The Choice Of Ics/laba Matter?
    Johansson, G.
    Janson, C.
    Stallberg, B.
    Lisspers, K.
    Stratelis, G.
    Jorgensen, L.
    Larsson, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [25] Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study
    Monteagudo, Monica
    Nunez, Alexa
    Barrecheguren, Miriam
    Miravitlles, Marc
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (10): : 699 - 707
  • [26] Does adherence to ICS/LABA therapy affect response to mepolizumab in the treatment of severe asthma?
    d'Ancona, Grainne
    Green, Linda
    Fernandes, Mariana
    Roxas, Cris
    Osman, Leyla
    Stewart-Knight, Kirsten
    Kavanagh, Joanna
    Nanzer-Kelly, Alexandra
    Jackson, David
    Kent, Brian
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [27] Effectiveness of ICS/LABA Compared With SABA as Relief Medications for Asthma
    Karamanis, Amber
    Bleacher, Heather
    DeSanto, Kristen
    AMERICAN FAMILY PHYSICIAN, 2023, 108 (05) : 515 - 516
  • [28] Comparative Adherence of ICS/LABA Products in Elderly Asthma Patients
    Tadrous, Mina
    Martins, Diana
    Yao, Zhan
    Stanbrook, Matthew
    Singh, Samantha
    Juurlink, David N.
    Mamdani, Muhammad M.
    Gomes, Tara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 488 - 489
  • [29] CURRENT POSITION OF ICS/LABA COMBINATION THERAPY IN ASTHMA AND COPD IN PRIMARY AND SECONDARY CARE IN GERMANY - DELPHI CONSENSUS RESEARCH
    Latif, F.
    Bechtel, B.
    Palovis, L.
    Kardos, P.
    VALUE IN HEALTH, 2012, 15 (07) : A567 - A567
  • [30] Seasonal Asthma Exacerbation and Viral Association in a Pediatric Population Receiving ICS ± LABA Therapy
    Prazma, C. M.
    Prillaman, B. A.
    Gern, J. E.
    Stempel, D. A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB164 - AB164
12345